Reference: https://www.nmn.com/news/new-harvard-study-shows-nmn-supplement-enhances-blood-vessel-formation
A collaborative study by researchers from Harvard Medical School, Princeton University, and institutions in Switzerland has revealed that nicotinamide mononucleotide (NMN), a precursor to NAD+ (nicotinamide adenine dinucleotide), plays a critical role in combating age-related decline in blood vessel formation.
The research highlights NMN's potential in rejuvenating the vascular system, which tends to lose its regenerative ability with age.
Key findings of the study include:
This research underscores the broader potential of NMN in age-related health interventions, particularly in improving circulation, promoting tissue repair, and maintaining overall cardiovascular health.
It also opens the door for further exploration into combined therapies that leverage NMN with other natural compounds for enhanced efficacy in slowing or reversing aspects of the aging process.